PDB Short entry for 2G5W HEADER OXIDOREDUCTASE 23-FEB-06 2G5W TITLE X-RAY CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA 12-OXOPHYTODIENOATE TITLE 2 REDUCTASE ISOFORM 3 (ATOPR3) IN COMPLEX WITH 8-ISO PROSTAGLANDIN A1 TITLE 3 AND ITS COFACTOR, FLAVIN MONONUCLEOTIDE. COMPND MOL_ID: 1; COMPND 2 MOLECULE: 12-OXOPHYTODIENOATE REDUCTASE 3; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: 12-OXOPHYTODIENOATE- 10,11-REDUCTASE 3, OPDA-REDUCTASE 3, COMPND 5 DELAYED DEHISCENCE 1, ATOPR3; COMPND 6 EC: 1.3.1.42; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ARABIDOPSIS THALIANA; SOURCE 3 ORGANISM_COMMON: THALE CRESS; SOURCE 4 ORGANISM_TAXID: 3702; SOURCE 5 GENE: AT2G06050; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: ROSETTA(DE3) PLACI RARE; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PVP 13 KEYWDS AT2G06050, OPR ISOFORM 3, FLAVOPROTEIN, FLAVOENZYME, OXIDOREDUCTASE, KEYWDS 2 XENOBIOTIC REDUCTASE, OLD YELLOW ENZYME, SECONDARY MESSENGER, KEYWDS 3 STRUCTURAL GENOMICS FUNCTIONAL FOLLOW-UP STUDY, PROTEIN STRUCTURE KEYWDS 4 INITIATIVE, PSI, CENTER FOR EUKARYOTIC STRUCTURAL GENOMICS, CESG EXPDTA X-RAY DIFFRACTION AUTHOR B.W.HAN,T.E.MALONE,C.A.BINGMAN,G.E.WESENBERG,G.N.PHILLIPS JR., AUTHOR 2 B.G.FOX,CENTER FOR EUKARYOTIC STRUCTURAL GENOMICS (CESG) REVDAT 6 30-AUG-23 2G5W 1 REMARK REVDAT 5 18-OCT-17 2G5W 1 REMARK REVDAT 4 24-OCT-12 2G5W 1 JRNL VERSN REVDAT 3 24-FEB-09 2G5W 1 VERSN REVDAT 2 04-JUL-06 2G5W 1 EXPDTA REVDAT 1 04-APR-06 2G5W 0 JRNL AUTH B.W.HAN,T.E.MALONE,D.J.KIM,C.A.BINGMAN,H.J.KIM,B.G.FOX, JRNL AUTH 2 G.N.PHILLIPS JRNL TITL CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA JRNL TITL 2 12-OXOPHYTODIENOATE REDUCTASE ISOFORM 3 IN COMPLEX WITH JRNL TITL 3 8-ISO PROSTAGLANDIN A(1). JRNL REF PROTEINS V. 79 3236 2011 JRNL REFN ISSN 0887-3585 JRNL PMID 21915915 JRNL DOI 10.1002/PROT.23153 REMARK 2 REMARK 2 RESOLUTION. 2.58 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REFMAC_5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.58 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.83 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 81.9 REMARK 3 NUMBER OF REFLECTIONS : 22704 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.205 REMARK 3 R VALUE (WORKING SET) : 0.202 REMARK 3 FREE R VALUE : 0.264 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.955 REMARK 3 FREE R VALUE TEST SET COUNT : 1125 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.58 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.64 REMARK 3 REFLECTION IN BIN (WORKING SET) : 927 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 47.74 REMARK 3 BIN R VALUE (WORKING SET) : 0.2900 REMARK 3 BIN FREE R VALUE SET COUNT : 36 REMARK 3 BIN FREE R VALUE : 0.4030 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5623 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 110 REMARK 3 SOLVENT ATOMS : 108 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 39.82 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.00300 REMARK 3 B22 (A**2) : -4.13500 REMARK 3 B33 (A**2) : 7.13800 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.385 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.272 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 12.958 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.926 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.878 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5873 ; 0.006 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7961 ; 0.977 ; 1.974 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 725 ; 5.059 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 262 ;35.206 ;23.473 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 925 ;14.839 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 40 ;14.239 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 852 ; 0.063 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4518 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2800 ; 0.183 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 4003 ; 0.302 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 246 ; 0.117 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 57 ; 0.164 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 4 ; 0.125 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3706 ; 0.552 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5782 ; 1.071 ; 4.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2488 ; 1.503 ; 6.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2179 ; 2.301 ; 8.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL PLUS MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2G5W COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-FEB-06. REMARK 100 THE DEPOSITION ID IS D_1000036727. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-AUG-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-D REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98244 REMARK 200 MONOCHROMATOR : INDIRECT LIQUID NITROGEN COOLED REMARK 200 DOUBLE CRYSTAL MONOCHROMATOR REMARK 200 WITH SI-111 CRYSTALS REMARK 200 OPTICS : PAIR OF BIMORPH, RHODIUM COATED REMARK 200 KIRKPATRICK-BAEZ MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22750 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.580 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 82.0 REMARK 200 DATA REDUNDANCY : 6.100 REMARK 200 R MERGE (I) : 0.15700 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.5490 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.58 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.67 REMARK 200 COMPLETENESS FOR SHELL (%) : 50.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.90 REMARK 200 R MERGE FOR SHELL (I) : 0.36600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.423 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 1Q45 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.68 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.49 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN SOLUTION (10 MG/ML PROTEIN, REMARK 280 0.10 M SODIUM CHLORIDE, 0.0003 M TECP, 0.010 M MES, PH 6.0) REMARK 280 MIXED IN A 1:1 RATIO WITH THE WELL SOLUTION (8.75-10.0% MEPEG REMARK 280 5000, 0.275-0.350 M GLYCINE, 0.10 M TRIETHANOLAMINE PH 8.0), REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 39.85100 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 61.79150 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.30400 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 61.79150 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 39.85100 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.30400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THERE ARE 2 BIOLOGICAL UNITS IN THE REMARK 300 ASYMMETRIC UNIT (CHAIN A AND CHAIN B) REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 THR A 2 REMARK 465 ALA A 3 REMARK 465 ALA A 4 REMARK 465 GLN A 5 REMARK 465 GLY A 6 REMARK 465 ASN A 7 REMARK 465 TYR A 285 REMARK 465 HIS A 286 REMARK 465 ALA A 287 REMARK 465 TYR A 288 REMARK 465 GLY A 289 REMARK 465 GLN A 290 REMARK 465 THR A 291 REMARK 465 GLU A 292 REMARK 465 SER A 293 REMARK 465 GLY A 294 REMARK 465 ARG A 295 REMARK 465 GLN A 296 REMARK 465 GLY A 297 REMARK 465 SER A 298 REMARK 465 ASP A 299 REMARK 465 GLU A 300 REMARK 465 GLU A 301 REMARK 465 PHE A 388 REMARK 465 SER A 389 REMARK 465 ARG A 390 REMARK 465 LEU A 391 REMARK 465 MET B 1 REMARK 465 THR B 2 REMARK 465 ALA B 3 REMARK 465 ALA B 4 REMARK 465 GLN B 5 REMARK 465 GLY B 6 REMARK 465 ASN B 7 REMARK 465 SER B 8 REMARK 465 GLY B 289 REMARK 465 GLN B 290 REMARK 465 THR B 291 REMARK 465 GLU B 292 REMARK 465 SER B 293 REMARK 465 GLY B 294 REMARK 465 ARG B 295 REMARK 465 GLN B 296 REMARK 465 GLY B 297 REMARK 465 SER B 298 REMARK 465 ASP B 299 REMARK 465 ALA B 386 REMARK 465 PRO B 387 REMARK 465 PHE B 388 REMARK 465 SER B 389 REMARK 465 ARG B 390 REMARK 465 LEU B 391 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 18 72.06 -101.61 REMARK 500 ILE A 80 24.27 -141.70 REMARK 500 ASN A 121 16.73 58.18 REMARK 500 ILE A 201 -51.42 -122.55 REMARK 500 ASN A 202 95.92 -69.61 REMARK 500 ASP A 203 42.44 -105.50 REMARK 500 HIS A 245 125.98 -36.95 REMARK 500 ASN A 324 -157.34 -123.99 REMARK 500 ASP A 351 40.22 -106.07 REMARK 500 PRO B 56 103.92 -58.90 REMARK 500 ASP B 206 -157.98 -90.31 REMARK 500 ASN B 324 -162.88 -116.14 REMARK 500 ASP B 351 43.38 -101.76 REMARK 500 VAL B 376 -57.36 -126.22 REMARK 500 TYR B 379 -53.56 -125.34 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FMN A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 8PG A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FMN B 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 8PG B 404 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1Q45 RELATED DB: PDB REMARK 900 SAME PROTEIN WITHOUT 8PG REMARK 900 RELATED ID: GO.8210 RELATED DB: TARGETDB DBREF 2G5W A 1 391 UNP Q9FUP0 OPR3_ARATH 1 391 DBREF 2G5W B 1 391 UNP Q9FUP0 OPR3_ARATH 1 391 SEQRES 1 A 391 MET THR ALA ALA GLN GLY ASN SER ASN GLU THR LEU PHE SEQRES 2 A 391 SER SER TYR LYS MET GLY ARG PHE ASP LEU SER HIS ARG SEQRES 3 A 391 VAL VAL LEU ALA PRO MET THR ARG CYS ARG ALA LEU ASN SEQRES 4 A 391 GLY VAL PRO ASN ALA ALA LEU ALA GLU TYR TYR ALA GLN SEQRES 5 A 391 ARG THR THR PRO GLY GLY PHE LEU ILE SER GLU GLY THR SEQRES 6 A 391 MET VAL SER PRO GLY SER ALA GLY PHE PRO HIS VAL PRO SEQRES 7 A 391 GLY ILE TYR SER ASP GLU GLN VAL GLU ALA TRP LYS GLN SEQRES 8 A 391 VAL VAL GLU ALA VAL HIS ALA LYS GLY GLY PHE ILE PHE SEQRES 9 A 391 CYS GLN LEU TRP HIS VAL GLY ARG ALA SER HIS ALA VAL SEQRES 10 A 391 TYR GLN PRO ASN GLY GLY SER PRO ILE SER SER THR ASN SEQRES 11 A 391 LYS PRO ILE SER GLU ASN ARG TRP ARG VAL LEU LEU PRO SEQRES 12 A 391 ASP GLY SER HIS VAL LYS TYR PRO LYS PRO ARG ALA LEU SEQRES 13 A 391 GLU ALA SER GLU ILE PRO ARG VAL VAL GLU ASP TYR CYS SEQRES 14 A 391 LEU SER ALA LEU ASN ALA ILE ARG ALA GLY PHE ASP GLY SEQRES 15 A 391 ILE GLU ILE HIS GLY ALA HIS GLY TYR LEU ILE ASP GLN SEQRES 16 A 391 PHE LEU LYS ASP GLY ILE ASN ASP ARG THR ASP GLN TYR SEQRES 17 A 391 GLY GLY SER ILE ALA ASN ARG CYS ARG PHE LEU LYS GLN SEQRES 18 A 391 VAL VAL GLU GLY VAL VAL SER ALA ILE GLY ALA SER LYS SEQRES 19 A 391 VAL GLY VAL ARG VAL SER PRO ALA ILE ASP HIS LEU ASP SEQRES 20 A 391 ALA THR ASP SER ASP PRO LEU SER LEU GLY LEU ALA VAL SEQRES 21 A 391 VAL GLY MET LEU ASN LYS LEU GLN GLY VAL ASN GLY SER SEQRES 22 A 391 LYS LEU ALA TYR LEU HIS VAL THR GLN PRO ARG TYR HIS SEQRES 23 A 391 ALA TYR GLY GLN THR GLU SER GLY ARG GLN GLY SER ASP SEQRES 24 A 391 GLU GLU GLU ALA LYS LEU MET LYS SER LEU ARG MET ALA SEQRES 25 A 391 TYR ASN GLY THR PHE MET SER SER GLY GLY PHE ASN LYS SEQRES 26 A 391 GLU LEU GLY MET GLN ALA VAL GLN GLN GLY ASP ALA ASP SEQRES 27 A 391 LEU VAL SER TYR GLY ARG LEU PHE ILE ALA ASN PRO ASP SEQRES 28 A 391 LEU VAL SER ARG PHE LYS ILE ASP GLY GLU LEU ASN LYS SEQRES 29 A 391 TYR ASN ARG LYS THR PHE TYR THR GLN ASP PRO VAL VAL SEQRES 30 A 391 GLY TYR THR ASP TYR PRO PHE LEU ALA PRO PHE SER ARG SEQRES 31 A 391 LEU SEQRES 1 B 391 MET THR ALA ALA GLN GLY ASN SER ASN GLU THR LEU PHE SEQRES 2 B 391 SER SER TYR LYS MET GLY ARG PHE ASP LEU SER HIS ARG SEQRES 3 B 391 VAL VAL LEU ALA PRO MET THR ARG CYS ARG ALA LEU ASN SEQRES 4 B 391 GLY VAL PRO ASN ALA ALA LEU ALA GLU TYR TYR ALA GLN SEQRES 5 B 391 ARG THR THR PRO GLY GLY PHE LEU ILE SER GLU GLY THR SEQRES 6 B 391 MET VAL SER PRO GLY SER ALA GLY PHE PRO HIS VAL PRO SEQRES 7 B 391 GLY ILE TYR SER ASP GLU GLN VAL GLU ALA TRP LYS GLN SEQRES 8 B 391 VAL VAL GLU ALA VAL HIS ALA LYS GLY GLY PHE ILE PHE SEQRES 9 B 391 CYS GLN LEU TRP HIS VAL GLY ARG ALA SER HIS ALA VAL SEQRES 10 B 391 TYR GLN PRO ASN GLY GLY SER PRO ILE SER SER THR ASN SEQRES 11 B 391 LYS PRO ILE SER GLU ASN ARG TRP ARG VAL LEU LEU PRO SEQRES 12 B 391 ASP GLY SER HIS VAL LYS TYR PRO LYS PRO ARG ALA LEU SEQRES 13 B 391 GLU ALA SER GLU ILE PRO ARG VAL VAL GLU ASP TYR CYS SEQRES 14 B 391 LEU SER ALA LEU ASN ALA ILE ARG ALA GLY PHE ASP GLY SEQRES 15 B 391 ILE GLU ILE HIS GLY ALA HIS GLY TYR LEU ILE ASP GLN SEQRES 16 B 391 PHE LEU LYS ASP GLY ILE ASN ASP ARG THR ASP GLN TYR SEQRES 17 B 391 GLY GLY SER ILE ALA ASN ARG CYS ARG PHE LEU LYS GLN SEQRES 18 B 391 VAL VAL GLU GLY VAL VAL SER ALA ILE GLY ALA SER LYS SEQRES 19 B 391 VAL GLY VAL ARG VAL SER PRO ALA ILE ASP HIS LEU ASP SEQRES 20 B 391 ALA THR ASP SER ASP PRO LEU SER LEU GLY LEU ALA VAL SEQRES 21 B 391 VAL GLY MET LEU ASN LYS LEU GLN GLY VAL ASN GLY SER SEQRES 22 B 391 LYS LEU ALA TYR LEU HIS VAL THR GLN PRO ARG TYR HIS SEQRES 23 B 391 ALA TYR GLY GLN THR GLU SER GLY ARG GLN GLY SER ASP SEQRES 24 B 391 GLU GLU GLU ALA LYS LEU MET LYS SER LEU ARG MET ALA SEQRES 25 B 391 TYR ASN GLY THR PHE MET SER SER GLY GLY PHE ASN LYS SEQRES 26 B 391 GLU LEU GLY MET GLN ALA VAL GLN GLN GLY ASP ALA ASP SEQRES 27 B 391 LEU VAL SER TYR GLY ARG LEU PHE ILE ALA ASN PRO ASP SEQRES 28 B 391 LEU VAL SER ARG PHE LYS ILE ASP GLY GLU LEU ASN LYS SEQRES 29 B 391 TYR ASN ARG LYS THR PHE TYR THR GLN ASP PRO VAL VAL SEQRES 30 B 391 GLY TYR THR ASP TYR PRO PHE LEU ALA PRO PHE SER ARG SEQRES 31 B 391 LEU HET FMN A 401 31 HET 8PG A 402 24 HET FMN B 403 31 HET 8PG B 404 24 HETNAM FMN FLAVIN MONONUCLEOTIDE HETNAM 8PG (8S,12S)-15S-HYDROXY-9-OXOPROSTA-10Z,13E-DIEN-1-OIC HETNAM 2 8PG ACID HETSYN FMN RIBOFLAVIN MONOPHOSPHATE HETSYN 8PG 8-ISO PROSTAGLANDIN A1 (8-ISO PGA1) FORMUL 3 FMN 2(C17 H21 N4 O9 P) FORMUL 4 8PG 2(C20 H32 O4) FORMUL 7 HOH *108(H2 O) HELIX 1 1 ALA A 37 VAL A 41 5 5 HELIX 2 2 ASN A 43 THR A 54 1 12 HELIX 3 3 SER A 82 LYS A 99 1 18 HELIX 4 4 HIS A 115 GLY A 123 5 9 HELIX 5 5 GLU A 157 SER A 159 5 3 HELIX 6 6 GLU A 160 ALA A 178 1 19 HELIX 7 7 ILE A 193 LYS A 198 1 6 HELIX 8 8 SER A 211 GLY A 231 1 21 HELIX 9 9 ASP A 244 ALA A 248 5 5 HELIX 10 10 ASP A 252 GLY A 272 1 21 HELIX 11 11 GLU A 302 TYR A 313 1 12 HELIX 12 12 ASN A 324 GLN A 334 1 11 HELIX 13 13 GLY A 343 ASN A 349 1 7 HELIX 14 14 ASP A 351 ILE A 358 1 8 HELIX 15 15 ASN A 366 PHE A 370 5 5 HELIX 16 16 ALA B 37 VAL B 41 5 5 HELIX 17 17 ASN B 43 THR B 54 1 12 HELIX 18 18 SER B 82 ALA B 98 1 17 HELIX 19 19 HIS B 115 GLY B 123 5 9 HELIX 20 20 GLU B 160 GLY B 179 1 20 HELIX 21 21 ILE B 193 LYS B 198 1 6 HELIX 22 22 SER B 211 GLY B 231 1 21 HELIX 23 23 ASP B 244 ALA B 248 5 5 HELIX 24 24 ASP B 252 GLY B 272 1 21 HELIX 25 25 GLU B 300 TYR B 313 1 14 HELIX 26 26 ASN B 324 GLN B 334 1 11 HELIX 27 27 GLY B 343 ASN B 349 1 7 HELIX 28 28 ASP B 351 ILE B 358 1 8 HELIX 29 29 ASN B 366 PHE B 370 5 5 SHEET 1 A 2 TYR A 16 MET A 18 0 SHEET 2 A 2 PHE A 21 LEU A 23 -1 O LEU A 23 N TYR A 16 SHEET 1 B 9 VAL A 27 LEU A 29 0 SHEET 2 B 9 PHE A 59 MET A 66 1 O PHE A 59 N LEU A 29 SHEET 3 B 9 PHE A 102 TRP A 108 1 O PHE A 104 N SER A 62 SHEET 4 B 9 GLY A 182 GLY A 187 1 O GLU A 184 N LEU A 107 SHEET 5 B 9 VAL A 235 VAL A 239 1 O ARG A 238 N ILE A 185 SHEET 6 B 9 TYR A 277 THR A 281 1 O HIS A 279 N VAL A 237 SHEET 7 B 9 PHE A 317 SER A 320 1 O MET A 318 N LEU A 278 SHEET 8 B 9 LEU A 339 TYR A 342 1 O LEU A 339 N SER A 319 SHEET 9 B 9 VAL A 27 LEU A 29 1 N VAL A 28 O TYR A 342 SHEET 1 C 2 ILE A 126 SER A 127 0 SHEET 2 C 2 ARG A 154 ALA A 155 1 O ARG A 154 N SER A 127 SHEET 1 D 2 VAL A 140 LEU A 141 0 SHEET 2 D 2 HIS A 147 VAL A 148 -1 O VAL A 148 N VAL A 140 SHEET 1 E 2 TYR B 16 MET B 18 0 SHEET 2 E 2 PHE B 21 LEU B 23 -1 O LEU B 23 N TYR B 16 SHEET 1 F 9 VAL B 27 LEU B 29 0 SHEET 2 F 9 PHE B 59 MET B 66 1 O PHE B 59 N LEU B 29 SHEET 3 F 9 PHE B 102 TRP B 108 1 O GLN B 106 N THR B 65 SHEET 4 F 9 GLY B 182 GLY B 187 1 O GLU B 184 N LEU B 107 SHEET 5 F 9 VAL B 235 VAL B 239 1 O GLY B 236 N ILE B 183 SHEET 6 F 9 TYR B 277 THR B 281 1 O HIS B 279 N VAL B 237 SHEET 7 F 9 PHE B 317 SER B 320 1 O MET B 318 N LEU B 278 SHEET 8 F 9 LEU B 339 TYR B 342 1 O SER B 341 N SER B 319 SHEET 9 F 9 VAL B 27 LEU B 29 1 N VAL B 28 O VAL B 340 SHEET 1 G 2 ILE B 126 SER B 127 0 SHEET 2 G 2 ARG B 154 ALA B 155 1 O ARG B 154 N SER B 127 SHEET 1 H 2 VAL B 140 LEU B 141 0 SHEET 2 H 2 HIS B 147 VAL B 148 -1 O VAL B 148 N VAL B 140 SITE 1 AC1 21 ALA A 30 PRO A 31 MET A 32 THR A 33 SITE 2 AC1 21 GLY A 64 GLN A 106 HIS A 186 HIS A 189 SITE 3 AC1 21 ARG A 238 THR A 281 SER A 320 GLY A 321 SITE 4 AC1 21 GLY A 322 TYR A 342 GLY A 343 ARG A 344 SITE 5 AC1 21 PHE A 370 TYR A 371 8PG A 402 HOH A 425 SITE 6 AC1 21 HOH A 454 SITE 1 AC2 11 HIS A 186 HIS A 189 TYR A 191 PRO A 283 SITE 2 AC2 11 ARG A 284 ARG A 367 TYR A 371 FMN A 401 SITE 3 AC2 11 HOH A 465 HIS B 286 TYR B 288 SITE 1 AC3 19 ALA B 30 PRO B 31 MET B 32 THR B 33 SITE 2 AC3 19 GLY B 64 GLN B 106 HIS B 186 ARG B 238 SITE 3 AC3 19 THR B 281 SER B 320 GLY B 321 GLY B 322 SITE 4 AC3 19 TYR B 342 GLY B 343 ARG B 344 PHE B 370 SITE 5 AC3 19 TYR B 371 8PG B 404 HOH B 422 SITE 1 AC4 5 HIS B 186 HIS B 189 TYR B 191 TYR B 371 SITE 2 AC4 5 FMN B 403 CRYST1 79.702 86.608 123.583 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012550 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011550 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008090 0.00000